Resources
17 Results (showing 1 - 10)
Results sorted by posted date (oldest first)
Results sorted by posted date (oldest first)
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Supreme Court Room on Wednesday, March 4, 2020, at 4:15 PM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session for RCORP Implementation and MAT Expansion grantees was held in the Independence Ballroom Salons D & E on Friday, March 6, 2020, at 11:15 AM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Independence Ballroom Salons A -C on Friday, March 6, 2020, at 9:00 AM and 11:15 AM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Rapid Fire Session was held in the Independence Ballroom Salons D & E on Friday, March 6, 2020, at 9:00 AM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Archives Room on Wednesday, March 5, 2020, at 2:30 PM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Supreme Court Room on Wednesday, March 5, 2020, at 2:30 PM
Posted 10/14/2021 (updated 4/3/2024)
The presenter outlined the steps needed to effectively document, code, and bill for services including screening for SUD/OUD and providing care during the induction, stabilization, and maintenance phases of MAT. Individual state Medicaid issues are too numerous and were not specifically referred to on a state-by-state basis.
Gary Lucas, MSHI, Arch Pro Coding
Posted 10/14/2021 (updated 4/3/2024)
Stimulant intoxication, withdrawal, and psychosis have accepted and established treatment strategies. Several lifesaving harm reduction interventions/services are available. There are no Food and Drug Administration-approved medications for treatment of stimulant use disorder, although several are promising. Behavioral treatment, especially the use of contingency management (and other approaches with supportive evidence), has by far the best evidence of effectiveness. The presenter reviewed topics of importance to clinicians treating individuals with stimulant use disorder.
Rick Rawson, PhD, University of Vermont Rural Center of Excellence
Posted 6/3/2022 (updated 3/27/2024)
The opioid settlement is a significant opportunity to improve substance use disorder prevention, treatment, and recovery. By attending to the evidence base and leveraging other funding sources, we can transform our behavioral health system to work better for people with substance use disorder. The Steadman Group related their experience in facilitating opioid settlement governance so you can optimize your settlement spending!
Posted 7/26/2023 (updated 3/28/2024)
The FY22 RCORP-Implementation cohort is diverse and dynamic in every way, representing a wide variety of experience and possessing an unending amount of knowledge on SUD in rural areas. This session explored the different methods and practices this cohort uses in its efforts to address SUD prevention, treatment, and recovery. Participants had an opportunity to learn from and to build relationships with one another, which will, in turn strengthen, their RCORP projects. Additionally, they heard from RCORP program staff and the RCORP-Evaluation team about program updates and data utilization tools.